Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing?: A systematic review and meta-analysis

被引:219
作者
Petignat, Patrick [1 ]
Faltin, Daniel L.
Bruchim, Ilan
Train, Martin R.
Franco, Eduardo L.
Coutlee, Francois
机构
[1] Univ Hosp Geneva, Senol & Gynaecol Oncol Unit, CH-1211 Geneva 14, Switzerland
[2] Dianuro Perineol Ctr, Geneva, Switzerland
[3] McGill Univ, Gynaecol Oncol Serv, Montreal, PQ, Canada
[4] Univ Hosp Geneva, Div Anaesthesiol, Geneva, Switzerland
[5] McGill Univ, Div Canc Epidemiol, Montreal, PQ, Canada
[6] CHUM, Dept Microbiol & Infect Dis, Hop Notre Dame, Montreal, PQ, Canada
[7] Univ Montreal, Dept Microbiol & Immunol, Montreal, PQ H3C 3J7, Canada
关键词
cervical cancer; human papillomavirus; physician-sampling; screening; self-sampling;
D O I
10.1016/j.ygyno.2007.01.023
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objective. To compare the detection rate of genital human papillomavirus (HPV) infection in self- and physician-obtained samples. Design. Systematic review and meta-analysis. Data sources. Studies published between 1966 and November 2005 identified through Medline and Embase that compared both sampling methods. Main outcome measures. We calculated the concordance and kappa statistic between physician- and self-sampling and the difference between proportions of HPV positive samples. Weighted averages were reported with 95% confidence intervals (CI) using a random-effects model. Results. Eighteen studies (5441 participants) were included that evaluated broad HPV type categories, 10 (3688 patients) that of high-risk (HR) HPV and three (530) that of low-risk (LR) HPV A high level of concordance of 0.87 (95% CI, 0.82 to 0.91) between self- and physician-sampling was obtained for detection of HPV DNA (kappa 0.66, 95% CI, 0.56 to 0.76). The prevalence difference of HPV DNA between sampling methods was -0.5 (95% CI, -2.8 to 1.8). Results were similar when restricting the analysis to HR-HPV but the prevalence of LR-HPV types was higher in self-collected samples. Conclusion. Self-sampling was as sensitive as physician-obtained sampling to detect HR-HPV or HPV DNA. Self-sampling may be a suitable alternative method for studies on HPV transmission and vaccine trials. (C) 2007 Elsevier Inc. All rights reserved.
引用
收藏
页码:530 / 535
页数:6
相关论文
共 32 条
  • [1] Self-sampling versus physician-sampling for human papillomavirus testing
    Agorastos, T
    Dinas, K
    Lloveras, B
    Font, R
    Kornegay, JR
    Bontis, J
    de Sanjose, S
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 2005, 16 (11) : 727 - 729
  • [2] Comparison of type-specific human papillomavirus data from self and clinician directed sampling
    Baldwin, S
    Santos, C
    Brown, EM
    Nuño, T
    Giuliano, A
    Davis, J
    Garcia, F
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 97 (02) : 612 - 617
  • [3] Shanxi Province cervical cancer screening study II: Self-sampling for high-risk human papillomavirus compared to direct sampling for human papillomavirus and liquid based cervical cytology
    Belinson, JL
    Qiao, YL
    Pretorius, RG
    Zhang, WH
    Rong, SD
    Huang, MN
    Zhao, FH
    Wu, LY
    Ren, SD
    Huang, RD
    Washington, MF
    Pan, QJ
    Li, L
    Fife, D
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2003, 13 (06) : 819 - 826
  • [4] Chang Chi-Chang, 2002, Chang Gung Med J, V25, P664
  • [5] Coutlee F, 1997, J MED VIROL, V51, P42, DOI 10.1002/(SICI)1096-9071(199701)51:1<42::AID-JMV7>3.0.CO
  • [6] 2-S
  • [7] Primary cervical cancer screening by self-sampling of human papillomavirus DNA in internal medicine outpatient clinics
    Dannecker, C
    Siebert, U
    Thaler, CJ
    Kiermeir, D
    Hepp, H
    Hillemanns, P
    [J]. ANNALS OF ONCOLOGY, 2004, 15 (06) : 863 - 869
  • [8] THE ABSENCE OF GENITAL HUMAN PAPILLOMAVIRUS DNA IN VIRGINAL WOMEN
    FAIRLEY, CK
    CHEN, SJ
    TABRIZI, SN
    LEETON, K
    QUINN, MA
    GARLAND, SM
    [J]. INTERNATIONAL JOURNAL OF STD & AIDS, 1992, 3 (06) : 414 - 417
  • [9] Cross-sectional study of patient- and physician-collected cervical cytology and human papillomavirus
    Garcia, F
    Barker, B
    Santos, C
    Brown, EM
    Nuño, T
    Giuliano, A
    Davis, J
    [J]. OBSTETRICS AND GYNECOLOGY, 2003, 102 (02) : 266 - 272
  • [10] Gravitt PE, 2001, CANCER EPIDEM BIOMAR, V10, P95